Takeda Pharmaceutical Co Ltd – Strategy, SWOT and Corporate Finance Report
- Pages: 79
- Published: July 2019
- Report Code: MLPH7835FSA
Takeda Pharmaceutical Co Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company
Key Highlights
Takeda Pharmaceutical Company Ltd (Takeda) is a research-based pharmaceutical company which focuses on the research and development, manufacture, marketing, commercialization and import and export of pharmaceutical drugs and consumer health care products. The company manufactures and markets a wide range of products in therapy areas including gastrointestinal, rare diseases, oncology, neuroscience and plasma-derived therapies. Takeda markets its drugs worldwide through its subsidiaries and has production, and research and development facilities in North America, Europe and Asia. Takeda is headquartered in Chuo-ku, Osaka, Japan.
Scope
Detailed information on Takeda Pharmaceutical Co Ltd required for business and competitor intelligence needs
A study of the major internal and external factors affecting Takeda Pharmaceutical Co Ltd in the form of a SWOT analysis
An in-depth view of the business model of Takeda Pharmaceutical Co Ltd including a breakdown and examination of key business segments
News about Takeda Pharmaceutical Co Ltd, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Takeda Pharmaceutical Co Ltd and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Takeda Pharmaceutical Co Ltd as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Takeda Pharmaceutical Co Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
F. Hoffmann-La Roche Ltd
Janssen Biotech Inc
Novo Nordisk AS
Novartis AG
Celgene Corp
Biotest AG
Pfizer Inc
Grifols SA
Taisho Pharmaceutical Holdings Co Ltd
Bayer AG
AstraZeneca Plc
Amgen Inc
Sumitomo Chemical Co Ltd
Merck & Co Inc
Bristol-Myers Squibb Co
Johnson & Johnson
Octapharma AG
AbbVie Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.